Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8343)
All Articles published online
|
Publishing Process of This Article
|
Apr 7, 2019 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hoffmann P, Wehling C, Krisam J, Pfeiffenberger J, Belling N, Gauss A. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis. World J Gastroenterol 2019; 25(13): 1603-1617 [PMID: PMC6452230 DOI: 10.3748/wjg.v25.i13.1603] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i13/1603.htm |
| Number | Citing Articles |
| 1 |
Roberto Manzini, Marlene Schwarzfischer, Kirstin Atrott, Andrea Laimbacher, Silvia Lang, Marcin Wawrzyniak, Andreas Rickenbacher, Matthias Turina, Petr Hruz, Donata Lissner, Britta Siegmund, Gerhard Rogler, Michael Scharl, Marianne R Spalinger. Combination of Vedolizumab With Tacrolimus Is More Efficient Than Vedolizumab Alone in the Treatment of Experimental Colitis. Inflammatory Bowel Diseases 2021; 27(12): 1986 doi: 10.1093/ibd/izab063
|
| 2 |
Zhen-Peng Xu, Su-Yuan Shan, Er-Wei Cai, Yan-Yan Wu. Gegen Qinlian decoction inhibited M1 macrophage polarization and ulcerative colitis progression through regulating histone lactylation. Tissue and Cell 2024; 89: 102468 doi: 10.1016/j.tice.2024.102468
|
| 3 |
T. O. Briukhanova, O. A. Nakonechna, O. V Babenko. CURRENT STATUS, PROBLEMS AND PROSPECTS OF ULCERATIVE COLITIS MEDICAL CORRECTION (LITERATURE REVIEW). Bulletin of Problems Biology and Medicine 2023; 1(3): 28 doi: 10.29254/2077-4214-2023-3-170-28-39
|
| 4 |
Juan Luo, Yijie Wang, Xiangqian Dong, Wen Wang, Yanju Mu, Yang Sun, Fengrui Zhang, Yinglei Miao. miR-642a-5p increases glucocorticoid sensitivity by suppressing the TLR4 signalling pathway in THP-1 cells. Biochemistry and Biophysics Reports 2022; 32: 101356 doi: 10.1016/j.bbrep.2022.101356
|
| 5 |
Sujaata Dwadasi, Maryam Zafer, Donald Goens, Raghavendra Paknikar, Sushila Dalal, Russell D Cohen, Joel Pekow, David T Rubin, Atsushi Sakuraba, Dejan Micic. Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis. Inflammatory Bowel Diseases 2021; 27(10): 1620 doi: 10.1093/ibd/izaa326
|
| 6 |
Jacob E. Ollech, Sujaata Dwadasi, Victoria Rai, Noam Peleg, Inessa Normatov, Amanda Israel, Philip H. Sossenheimer, Britt Christensen, Joel Pekow, Sushila R. Dalal, Atsushi Sakuraba, Russell D. Cohen, David T. Rubin. Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid‐refractory ulcerative colitis. Alimentary Pharmacology & Therapeutics 2020; 51(6): 637 doi: 10.1111/apt.15616
|
| 7 |
Shankar Kumar, Richard Pollok, David Goldsmith. Renal and Urological Disorders Associated With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2023; 29(8): 1306 doi: 10.1093/ibd/izac140
|
| 8 |
Morris Gordon, Vassiliki Sinopoulou, Anthony K Akobeng, Mirela Pana, Rehab Gasiea, Gordon William Moran. Tacrolimus (FK506) for induction of remission in corticosteroid-refractory ulcerative colitis. Cochrane Database of Systematic Reviews 2022; 2022(4) doi: 10.1002/14651858.CD007216.pub2
|
| 9 |
G. Pellino, D. S. Keller, G. M. Sampietro, M. Carvello, V. Celentano, C. Coco, F. Colombo, A. Geccherle, G. Luglio, M. Rottoli, M. Scarpa, G. Sciaudone, G. Sica, L. Sofo, R. Zinicola, S. Leone, S. Danese, A. Spinelli, G. Delaini, F. Selvaggi, Imerio Angriman, Paola Caprino, Francesca Di Candido, Mirko Di Ruscio, Silvio Laureti, Gilberto Poggioli, Gianluca Rizzo, Giulia Roda, Franco Sacchetti, Stefano Scaringi, Bruno Sensi, Angela Variola, Committee Gianluca Pellino, Deborah S. Keller, Gianluca M. Sampietro, Salvatore Leone, Silvio Danese, Antonino Spinelli, GianGaetano Delaini, Francesco Selvaggi. Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis. Techniques in Coloproctology 2020; 24(5): 397 doi: 10.1007/s10151-020-02175-z
|
| 10 |
Ananya S Agnihotri, C.G. Ann Maria, Anitha Varghese, Pratap Mane, Brahmananda Chakraborty, Nidhin M. CoFe2O4-APTES nanocomposite for the selective determination of tacrolimus in dosage forms: Perspectives from computational studies. Surfaces and Interfaces 2022; 35: 102406 doi: 10.1016/j.surfin.2022.102406
|
| 11 |
Satoshi Nakata, Kazuki Kakimoto, Keijiro Numa, Naohiko Kinoshita, Yuka Kawasaki, Yoshihiro Tatsumi, Hideki Tawa, Ryoji Koshiba, Yuki Hirata, Kazuhiro Ota, Naokuni Sakiyama, Yuichi Kojima, Hiroki Nishikawa, Takuya Inoue, Toshihisa Takeuchi, Shinya Fukunishi, Takako Miyazaki, Shiro Nakamura, Kazuhide Higuchi. Risk Factors for Nephrotoxicity due to Tacrolimus Therapy for Ulcerative Colitis. Digestion 2022; 103(5): 339 doi: 10.1159/000524594
|
| 12 |
Iria Seoane-Viaño, Noemí Gómez-Lado, Héctor Lázare-Iglesias, Xurxo García-Otero, José Ramón Antúnez-López, Álvaro Ruibal, Juan Jesús Varela-Correa, Pablo Aguiar, Abdul W. Basit, Francisco J. Otero-Espinar, Miguel González-Barcia, Alvaro Goyanes, Asteria Luzardo-Álvarez, Anxo Fernández-Ferreiro. 3D Printed Tacrolimus Rectal Formulations Ameliorate Colitis in an Experimental Animal Model of Inflammatory Bowel Disease. Biomedicines 2020; 8(12): 563 doi: 10.3390/biomedicines8120563
|
| 13 |
The metabolomics analysis of cecal contents elucidates significant metabolites involved in the therapeutic effects of total flavonoids derived from Sonchus arvensis L. in male C57BL/6 mice with ulcerative colitis. Heliyon 2024; 10(12): e32790 doi: 10.1016/j.heliyon.2024.e32790
|
| 14 |
Fang Zhu, Jujia Zheng, Fang Xu, Yiyuan Xi, Jun Chen, Xiangwei Xu. Resveratrol Alleviates Dextran Sulfate Sodium-Induced Acute Ulcerative Colitis in Mice by Mediating PI3K/Akt/VEGFA Pathway. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.693982
|
| 15 |
Jason Hafron, Benjamin N. Breyer, Shreyas Joshi, Christopher Smith, Melissa R. Kaufman, Janet Okonski, Michael B. Chancellor. Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study. International Urology and Nephrology 2023; 56(1): 87 doi: 10.1007/s11255-023-03783-y
|
| 16 |
G. N. Tarasova, A. D. Zubova. Impact of ulcerative colitis therapy on the bacterial profile of the intestinal microbiota. South Russian Journal of Therapeutic Practice 2023; 4(3): 22 doi: 10.21886/2712-8156-2023-4-3-22-26
|
| 17 |
Qinghui Jia, Haihua Zhang, Yongmei Su, Xin Liu, Jiangsong Bai, Wuying Lang, Qiumei Shi, Minshan Feng. Strictosamide alleviates the inflammation in an acute ulcerative colitis (UC) model. Journal of Physiology and Biochemistry 2021; 77(2): 283 doi: 10.1007/s13105-021-00796-y
|
| 18 |
Chenthan Krishnakumar, Ashwin N. Ananthakrishnan, Brendan M. Boyle, Anne M. Griffiths, Neal S. LeLeiko, David R. Mack, James F. Markowitz, Joel R. Rosh, Cary G. Sauer, Thomas D. Walters, Erin Bonkowski, Lee A. Denson, Jeffrey S. Hyams, Subra Kugathasan. Early Change in Fecal Calprotectin Predicts One‐Year Outcome in Children Newly Diagnosed With Ulcerative Colitis. Journal of Pediatric Gastroenterology and Nutrition 2022; 74(1): 72 doi: 10.1097/MPG.0000000000003291
|
| 19 |
Zhenhua Bian, Yuwen Qin, Lin Li, Lianlin Su, Chenghao Fei, Yu Li, Minmin Hu, Xiaowei Chen, Wei Zhang, Chunqin Mao, Xiaohang Yuan, Tulin Lu, De Ji. Schisandra chinensis (Turcz.) Baill. Protects against DSS-induced colitis in mice: Involvement of TLR4/NF-κB/NLRP3 inflammasome pathway and gut microbiota. Journal of Ethnopharmacology 2022; 298: 115570 doi: 10.1016/j.jep.2022.115570
|
| 20 |
Xinya Yu, Xiaoxi Li, Yunchun Xu, Yuwei Li, Ye Zhou, Junhua Zhang, Le Guo. Resveratrol ameliorates ulcerative colitis by upregulating Nrf2/HO‑1 pathway activity: Integrating animal experiments and network pharmacology. Molecular Medicine Reports 2024; 29(5) doi: 10.3892/mmr.2024.13201
|
| 21 |
Ciclosporin/mercaptopurine/tacrolimus. Reactions Weekly 2019; 1761(1): 109 doi: 10.1007/s40278-019-64481-1
|
| 22 |
Shruthi Karthikeyan, Chetan Ambastha, Kian Keyashian. Acute severe ulcerative colitis: using JAK-STAT inhibitors for improved clinical outcomes. Frontiers in Gastroenterology 2024; 3 doi: 10.3389/fgstr.2024.1488288
|
| 23 |
Sudheer Kumar Vuyyuru, Olga Maria Nardone, Vipul Jairath. Predicting Outcome after Acute Severe Ulcerative Colitis: A Contemporary Review and Areas for Future Research. Journal of Clinical Medicine 2024; 13(15): 4509 doi: 10.3390/jcm13154509
|